丁香园 | 丁香通 | 人才 | 会议 | 药学 | 博客  
 点击次数:

肿瘤生物标记

转载请注明来自丁香园
发布日期:2012-06-16 14:45 文章来源:丁香园
分享到: 收藏夹 新浪微博 腾讯微博 开心网 豆瓣社区 人人网
关键词: 肿瘤生物标记 R&D Systems China 生物专题 丁香园   点击次数:

点此了解更多肿瘤生物标记信息>>


Tumor markers are endogenous proteins or metabolites whose amounts or modifications are indicative of tumor state, progression characteristics, and response to therapies. They are present in tumor tissues or body fluids and encompass a wide variety of molecules, including transcription factors, cell surface receptors, and secreted proteins. Effective tumor markers are in great demand since they have the potential to reduce cancer mortality rates by facilitating diagnosis of cancers at early stages and by helping to individualize treatments.


During the last decade, improved understanding of carcinogenesis and tumor progression has revealed a large number of potential tumor markers. It is predicted that even more will be discovered in the near future with the application of current technologies such as tissue microarrays, antibody arrays, and mass spectrometry. To apply these discoveries to patient care, vigorous validation and assay development for many tumor markers is currently underway. R&D Systems has a wide range of research reagents for use at every stage of the tumor marker development process. These products include a large collection of recombinant proteins, antibodies, and protein quantification kits (Quantikine ELISA kits and DuoSet ELISA development kits).


临床肿瘤生物标记

其它肿瘤生物标记

编辑: nina06

以下网友留言只代表网友个人观点,不代表网站观点